Kidney Transplant
Competing-risk model provides more accurate estimate of transplant waiting time
A simple median waiting time that did not account for censoring, death and other competing events underestimated time to organ transplantation by up to 61% compared with a competing-risk model, according to a study conducted in Switzerland.
Cognitive function before kidney transplant does not affect clinical outcomes
Adults with lower cognitive scores before kidney transplantation had similar kidney function, hospital length of stay and readmission and death rates as those with higher pre-transplant scores, according to study data.
Investors back eGenesis in pursuing pig-to-human transplant study
A biotechnology company developing compatible organs for transplantation to humans, eGenesis, secured financial backing that could eventually lead to a human trial of its bioengineered pig kidney, according to a company press release.
Transplant society asks CMS to delay launch of new payment model
The American Society of Transplantation has asked CMS to delay up to a year the launch of a 6-year demonstration aimed at increasing kidney transplants and improvements in graft survival.
Senate bill would require health plans to continue dialysis coverage for 30 months
A bipartisan bill introduced in the U.S. Senate would require private health plans to continue to pay for dialysis for beneficiaries with end-stage kidney disease while they coordinate a transition to Medicare coverage.
National Kidney Foundation launches patient-tailored learning tool for people with CKD
The National Kidney Foundation launched a new interactive portal that lets patients with chronic kidney disease learn more about their condition, according to a press release.
Real-world data confirm benefits of ravulizumab for atypical hemolytic uremic syndrome
Adults and children with atypical hemolytic uremic syndrome who switched from eculizumab to ravulizumab had stable renal function and hematologic values with similar safety seen in clinical trials, according to data from a registry study.
Legislators introduce bill to offer tax benefits to non-directed kidney donors
Legislators have introduced a bill that would provide up to $50,000 in tax benefits over 5 years to an individual who donates a non-directed kidney.
Phase 3 results for pegcetacoplan show reduced proteinuria, stabilized eGFR vs. placebo
Sobi and Apellis Pharmaceuticals Inc. announced results from the phase 3 Valiant study showing the drug pegcetacoplan reduced proteinuria and stabilized eGFR compared to placebo in patients with glomerulopathy or glomerulonephritis.
Patients with diabetes at time of kidney allograft loss may have lower survival
Patients who have diabetes at the time of kidney allograft loss may have a lower chance of survival compared without, according to .